🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Drugmakers, oil majors drag FTSE 100 lower; Avast surges

Published 15/07/2021, 08:24
© Reuters. FILE PHOTO: A worker shelters from the rain under a Union Flag umbrella as he passes the London Stock Exchange in London, Britain, October 1, 2008.  REUTERS/Toby Melville/File Photo
UK100
-
BP
-
RDSa
-
FTMC
-

By Amal S

(Reuters) - London's FTSE 100 marked its worst day in a week on Thursday dragged down by pharmaceutical and energy stocks, while UK-based cybersecurity firm Avast jumped to the top of the index amid merger talks.

The blue-chip FTSE 100 index ended 1.1% lower, weighed by drugmakers which fell 2.9%, with AstraZeneca (NASDAQ:AZN) and GlaxoSmithKline among the worst performers.

Avast Plc jumped 18.1% and was the top gainer on the FTSE 100 after revealing it was in advanced talks over a merger with peer NortonLifeLock Inc.

Bank of England Governor Andrew Bailey said the central bank would assess inflation data for things that could be temporary before taking a call on raising rates, while a roaring jobs market in June also showed growing inflation pressures from rising wages.

The BoE could also stop its government bond purchases early due to an unexpectedly sharp rise in inflation, interest rate-setter Michael Saunders said, the second top BoE official in two days to signal a possible reining in of its stimulus.

"There are a couple of central banks including the Bank of England where the narrative has shifted with noises starting around ending the measures. They are slowly prepping the markets before dropping the support as inflation figures are out of control," said Keith Temperton, equity sales trader at Forte Securities.

The FTSE 100 has gained 8.5% so far this year helped by record low interest rates, but a rise in inflationary pressures coupled with risks arising from a jump in local coronavirus infections have slowed the rise of the blue-chip index, leading it to underperform its wider European peers.

Energy sector dropped 2.5%, with oil majors Royal Dutch Shell (LON:RDSa) and BP (LON:BP) down 2.4% and 2.9%, respectively. [O/R]

© Reuters. FILE PHOTO: A worker shelters from the rain under a Union Flag umbrella as he passes the London Stock Exchange in London, Britain, October 1, 2008.  REUTERS/Toby Melville/File Photo

The mid-cap FTSE 250 index fell 1.0% as fears over rising inflation and a jump in virus cases affected the more domestically focused stocks.

Among stocks, the world's largest credit data company Experian was the top boost to the FTSE 100, up 2.8%, after it raised its annual outlook and posted a 31% jump in its first-quarter revenue. (Graphic: UK inflation pattern, https://fingfx.thomsonreuters.com/gfx/mkt/jbyprzywjpe/UK%20inflation%20graf.png)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.